Objective: To evaluate medical abortion by Domicilliary administration of mifepristone and Misoprostol by assessing efficacy and women's acceptability. Methods: This was a retrospective study of 80 patients done from Jan 2017 to Jan 2018. Women with amenorrhoea of less than or equal to 63 days are advised to self administer 200 mg Mifepristone orally at home on day1. 48 hrs later, oral 800 µg Misoprostol . All women followed up on day 14 of tab. Mifepristone for abortion confirmed by usg. Results: Efficacy of regimen was 100% in gestational age up to 49 days and 95.45 % in gestational age of 50-63 days. The overall success rate was 97.5%. most of the women were ready to choose same method in future if required. Conclusion: Medical abortion was simplified by Domicile use of oral mifepristone and Misoprostol as it required less hospital visits and less supervision by trained persons. Acceptability of home selfadministration was high. Hence home administration is safe and feasible for introduction into medical abortion services in India.
Introduction
Medical abortion consists of usage of drugs to terminate a pregnancy. It is an important alternative to surgical methods. WHO recommends initial dose of mifepristone followed by Misoprostol 36-48 hours later. In home medical abortion, pregnant woman takes mifepristone initially and later takes misoprostol at home. The home based medical abortion intends to simplify the abortion regime, give privacy at home and family members' support. In 2002, the Drug Controller of India approved mifepristone and misoprostol combination for medical abortion. Clinical trials from Turkey and the USA report rates of complete abortion from 91%-98% for pregnancies up to 9 weeks when administered at home 1 . A regime of reduced dose of mifepristone and misoprostol may increase the feasibility to provide non-invasive abortion in rural areas ; thereby greatly increasing access to safe abortion in India. 2 We thus assessed the feasibility and acceptability of such a simplified abortion regime. Most of the patients were Gravida 3. Most of the patients for MTP were at 6.1-7 weeks and Mean Gestational age was 49 days Most (43.75%) women had bleeding for 5-7 days Regime is highly Effective (100%) in early Gestational age 
Conclusion
Medical abortion was simplified by Domicilliary use of oral mifepristone and misoprostol as it required less hospital visits & less supervision. Women felt better at home as they could fulfill domestic responsibilities. Efficacy of regimen used in our study was excellent as success rate was 97.5%. The regimen was more effective for early gestational age (up to 49 days) .Minor side effects were treated by only symptomatically. Being non-invasive, women were more comforttable and accepted the regimen. This method can be used in an outpatient clinic provided referral is possible. Morbidity and mortality due to illegal abortions can be markedly reduced. Hence, domicile administration of oral mifepristone and misoprostol is safe and feasible for introduction into medical abortion services in India.
